UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis

Blood, 2021-04, Vol.137 (14), p.1970-1979

2021

Link zum Volltext

Verfügbarkeit prüfen

Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia

BMJ open, 2023-05, Vol.13 (5), p.e068310-e068310

2023

Link zum Volltext

Verfügbarkeit prüfen

The risk of postoperative deterioration of non-cardiac surgery patients with ICU referral status who are admitted to the regular ward: a retrospective observational cohort study

Patient safety in surgery, 2021-02, Vol.15 (1), p.10-10, Article 10

2021

Link zum Volltext

Verfügbarkeit prüfen

POPPY II Cohort Profile– a population-based linked cohort examining the patterns and outcomes of prescription opioid use in NSW, Australia, 2003-2018

International journal of population data science, 2022-08, Vol.7 (3)

2022

Link zum Volltext

Verfügbarkeit prüfen

W144 - Association of Opioid Analgesics, Benzodiazepines, Gabapentinoids, and Opioid Agonist Treatment With Mortality Among Individuals With Opioid Dependence

Drug and alcohol dependence, 2024-07, Vol.260

2024

Link zum Volltext

Verfügbarkeit prüfen

Association of Opioid Analgesics, Benzodiazepines, Gabapentinoids, and Opioid Agonist Treatment With Mortality Among Individuals With Opioid Dependence

Drug and alcohol dependence, 2024-07, Vol.260, p.110845, Article 110845

2024

Link zum Volltext

Verfügbarkeit prüfen

Temporal trends in co‐morbidities and cardiometabolic risk factors at the time of type 2 diabetes diagnosis in the UK

Diabetes, obesity & metabolism, 2021-05, Vol.23 (5), p.1150-1161

2021

Link zum Volltext

Verfügbarkeit prüfen

Age-Related Risk of Serious Fall Events and Opioid Analgesic Use

JAMA internal medicine, 2024-04, Vol.184 (4), p.394

2024

Link zum Volltext

Verfügbarkeit prüfen

Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality

The International journal of drug policy, 2024-01, Vol.123, p.104287-104287, Article 104287

2024

Link zum Volltext

Verfügbarkeit prüfen

A data‐informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data

Pharmacoepidemiology and drug safety, 2023-03, Vol.32 (3), p.352-365

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a Large Scale Advance Care Planning Co-Design Education Program for Chinese-Speaking People in Australia

American journal of hospice & palliative medicine, 2022-02, Vol.39 (2), p.178-183

2022

Link zum Volltext

Verfügbarkeit prüfen

Oxycodone initiation in Australia (2014–2018): Sociodemographic factors and preceding health service use

British journal of clinical pharmacology, 2024-07, Vol.90 (7), p.1656-1666

2024

Link zum Volltext

Verfügbarkeit prüfen

Do Patient Demographics and Performance Status Influence Opioid Dose in Cancer Pain?

American journal of hospice & palliative medicine, 2023-06, Vol.40 (6), p.607-612

2023

Link zum Volltext

Verfügbarkeit prüfen

Does cancer type and adjuvant analgesic prescribing influence opioid dose?—a retrospective cross-sectional study

Annals of palliative medicine, 2023-07, Vol.12 (4), p.783-790

2023

Link zum Volltext

Verfügbarkeit prüfen

Right or Left Primary Site of Colorectal Cancer: Outcomes From the Molecular Analysis of the AGITG MAX Trial

Clinical colorectal cancer, 2019-06, Vol.18 (2), p.141-148

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study

The lancet. Diabetes & endocrinology, 2018-04, Vol.6 (4), p.310-318

2018

Link zum Volltext

Verfügbarkeit prüfen

Results of a Phase III Double-Blind Study of the Addition of Tocilizumab Vs. Placebo to Cyclosporin/Methotrexate Gvhd Prophylaxis after HLA-Matched Allogeneic Stem Cell Transplantation

Blood, 2019-11, Vol.134 (Supplement_1), p.368-368

2019

Link zum Volltext

Verfügbarkeit prüfen

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study

The oncologist (Dayton, Ohio), 2017-09, Vol.22 (9), p.1117-1124

2017

Link zum Volltext

Verfügbarkeit prüfen

Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study

Diabetologia, 2015-09, Vol.58 (9), p.2035-2044

2015

Link zum Volltext

Verfügbarkeit prüfen

Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: analysis of the fenofibrate intervention and event lowering in diabetes (FIELD) study

Metabolism, clinical and experimental, 2016-05, Vol.65 (5), p.783-793

2016

Link zum Volltext

Verfügbarkeit prüfen

Performance of four published risk models to predict sentinel lymph-node involvement in Australian women with early breast cancer

Breast (Edinburgh), 2018-10, Vol.41, p.82-88

2018

Link zum Volltext

Verfügbarkeit prüfen

Five-Year Trajectories of Prescription Opioid Use

JAMA network open, 2023-08, Vol.6 (8), p.e2328159-e2328159

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(26)
Tagungsberichte
(2)

Sprache

Englisch
(28)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis

Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia

Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)

The risk of postoperative deterioration of non-cardiac surgery patients with ICU referral status who are admitted to the regular ward: a retrospective observational cohort study

POPPY II Cohort Profile– a population-based linked cohort examining the patterns and outcomes of prescription opioid use in NSW, Australia, 2003-2018

W144 - Association of Opioid Analgesics, Benzodiazepines, Gabapentinoids, and Opioid Agonist Treatment With Mortality Among Individuals With Opioid Dependence

Association of Opioid Analgesics, Benzodiazepines, Gabapentinoids, and Opioid Agonist Treatment With Mortality Among Individuals With Opioid Dependence

Temporal trends in co‐morbidities and cardiometabolic risk factors at the time of type 2 diabetes diagnosis in the UK

Age-Related Risk of Serious Fall Events and Opioid Analgesic Use

Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality

A data‐informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data

Evaluation of a Large Scale Advance Care Planning Co-Design Education Program for Chinese-Speaking People in Australia

Oxycodone initiation in Australia (2014–2018): Sociodemographic factors and preceding health service use

Do Patient Demographics and Performance Status Influence Opioid Dose in Cancer Pain?

Does cancer type and adjuvant analgesic prescribing influence opioid dose?—a retrospective cross-sectional study

Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer

Right or Left Primary Site of Colorectal Cancer: Outcomes From the Molecular Analysis of the AGITG MAX Trial

Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study

Results of a Phase III Double-Blind Study of the Addition of Tocilizumab Vs. Placebo to Cyclosporin/Methotrexate Gvhd Prophylaxis after HLA-Matched Allogeneic Stem Cell Transplantation

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study

Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study

Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: analysis of the fenofibrate intervention and event lowering in diabetes (FIELD) study

Performance of four published risk models to predict sentinel lymph-node involvement in Australian women with early breast cancer

Predictors of stopping chemotherapy early and short survival in patients with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) who have had ≥3 lines of prior chemotherapy: The GCIG symptom benefit study (SBS)

Five-Year Trajectories of Prescription Opioid Use

Suchergebnisse filtern